P12493 (GAG_HV1N5) Human immunodeficiency virus type 1 group M subtype B (isolate NY5)(HIV-1)
Gag polyprotein UniProtKBInterProInteractive Modelling
500 aa; Sequence (Fasta) ;
1 identical sequence: Human immunodeficiency virus 1: I6RF17
It is possible new templates exist for this target since these models were created.
Available Structures
120 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions |
Heteromer | |||||
| Assess | ||||||
| CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions |
Heteromer | |||||
| Assess | ||||||
| HIV-1 capsid lattice bound to dNTPs |
Heteromer | |||||
| Assess | ||||||
| HIV-1 capsid lattice bound to IP6 and Lenacapavir |
Heteromer | |||||
| Assess | ||||||
| HIV-1 CA lattice bound to IP6, pH 7.4 |
Heteromer | |||||
| Assess | ||||||
| HIV-1 CA lattice bound to IP6; from capsid-like particles |
Heteromer | |||||
| Assess | ||||||
| HIV-1 capsid lattice bound to IP6, pH 6.2 |
Heteromer | |||||
| Assess | ||||||
| Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide |
Heteromer Q16630; | 36×IOD; 24×CL; | ||||
| Assess | ||||||
| HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs bound to Nup153 peptide. |
Heteromer P49790; | |||||
| Assess | ||||||
| Structure of HIV-1 capsid declination in complex with CPSF6-FG peptide |
Heteromer Q16630; | |||||
| Assess | ||||||
| HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Sec24C peptide |
Heteromer | |||||
| Assess | ||||||
| HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to CPSF6 peptide |
Heteromer | |||||
| Assess | ||||||
| HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Nup153 peptide |
Heteromer P49790; | |||||
| Assess | ||||||
| HIV-1 mature capsid pentamer from CA-IP6 CLPs |
Heteromer | |||||
| Assess | ||||||
| HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Sec24C peptide. |
Heteromer P53992; | |||||
| Assess | ||||||
| HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Nup153 peptide |
Heteromer | |||||
| Assess | ||||||
| HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to CPSF6 peptide. |
Heteromer Q16630; | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with CPSF6 peptide, P6 crystal form |
Heteromer Q16630; | 6×CL; | ||||
| Assess | ||||||
| Structural basis of HIV-1 capsid recognition by CPSF6 |
Heteromer Q16630; | |||||
| Assess | ||||||
| Hexamer HIV-1 CA in complex with CPSF6 peptide, P212121 crystal form |
Heteromer Q16630; | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with Nup153 peptide, P6 crystal form |
Heteromer P49790; | |||||
| Assess | ||||||
| HIV-1 CA hexamer with NUP153 peptide - P1 crystal form |
Heteromer P49790; | 2×FLU; | ||||
| Assess | ||||||
| Structure of the native full-length HIV-1 capsid protein in complex with Nup153 peptide |
Heteromer P49790; | 42×IOD; 12×CL; | ||||
| Assess | ||||||
| HIV-1 CA hexamer with NUP153 peptide - R3 crystal form |
Heteromer P49790; | 3×FLU; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with Nup153 peptide, P212121 crystal form |
Heteromer P49790; | 1×CL; | ||||
| Assess | ||||||
| HIV-1 CA 1/2-hexamer-EE |
Heteromer | |||||
| Assess | ||||||
| Cysteine stabilized hexameric HIV-1 CA in complex with SEC24C peptide |
Heteromer P53992; | 18×IOD; 18×CL; | ||||
| Assess | ||||||
| Llama VHH in complex with p24 |
Heteromer | |||||
| Assess | ||||||
| Structure of the complex between calmodulin and the binding domain of HIV-1 matrix protein |
Heteromer P0DP29; | 4×CA; | ||||
| Assess | ||||||
| T=1 particle HIV-1 CA G60A/G61P | homo-60-mer | 120×IHP; | ||||
| Assess | ||||||
| T=1 particle HIV-1 CA G60A/G61P/M66A | homo-60-mer | 120×IHP; | ||||
| Assess | ||||||
| T=1 particle HIV-1 CA M66A | homo-60-mer | 120×IHP; | ||||
| Assess | ||||||
| Structure of HIV-1 capsid declination | homo-35-mer | 10×IHP; | ||||
| Assess | ||||||
| Immature HIV-1 matrix structure | homo-24-mer | 24×MYR; | ||||
| Assess | ||||||
| Mature HIV-1 matrix structure | homo-24-mer | 24×MYR; 24×PIO; | ||||
| Assess | ||||||
| An atomic model of HIV-1 CA-SP1 reveals structures regulating assembly and maturation | homo-18-mer | |||||
| Assess | ||||||
| E45A/R132T mutant of HIV-1 capsid protein | homo-6-mer | 48×IOD; 42×CL; | ||||
| Assess | ||||||
| Structure of the R18A mutant of the HIV-1 capsid protein | homo-6-mer | 54×IOD; 42×CL; | ||||
| Assess | ||||||
| Structure of the E28A mutant of the HIV-1 capsid protein | homo-6-mer | 72×IOD; 36×CL; | ||||
| Assess | ||||||
| E45A mutant of HIV-1 capsid protein (other crystal form) | homo-6-mer | 60×IOD; 24×CL; | ||||
| Assess | ||||||
| Structure of the R18A/E28A mutant of the HIV-1 capsid protein | homo-6-mer | 42×IOD; 42×CL; | ||||
| Assess | ||||||
| Structure of the P122A mutant of the HIV-1 capsid protein | homo-6-mer | 48×IOD; 30×CL; | ||||
| Assess | ||||||
| Hexameric HIV-1 (M-group) CA R120 mutant | homo-6-mer | 12×IOD; 30×CL; 6×BME; | ||||
| Assess | ||||||
| Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid protein | homo-6-mer | 54×IOD; 36×CL; | ||||
| Assess | ||||||
| Structure of the V11I/T58A/P122A mutant of the HIV-1 capsid protein | homo-6-mer | 60×IOD; 36×CL; | ||||
| Assess | ||||||
| P38A mutant of HIV-1 capsid protein | homo-6-mer | 48×IOD; 30×CL; | ||||
| Assess | ||||||
| Structure of the native full-length HIV-1 capsid protein | homo-6-mer | 42×IOD; 12×CL; | ||||
| Assess | ||||||
| E45A mutant of the HIV-1 capsid protein | homo-6-mer | 18×IOD; 72×CL; | ||||
| Assess | ||||||
| P38A/T216I mutant of the HIV-1 capsid protein | homo-6-mer | 36×IOD; 36×CL; | ||||
| Assess | ||||||
| N74D mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF74) | homo-6-mer | 6×1B0; 36×IOD; | ||||
| Assess | ||||||
| HIV-1 CA hexamer in complex with IP6, orthorhombic crystal form | homo-6-mer | 2×IHP; | ||||
| Assess | ||||||
| Structure of the wild-type native full-length HIV-1 capsid protein in complex with ZW-1261 | homo-6-mer | 6×YTG; 30×IOD; | ||||
| Assess | ||||||
| Structure of the native full-length HIV-1 capsid protein in complex with PF-3450074 (PF74) | homo-6-mer | 36×IOD; 12×CL; 6×1B0; | ||||
| Assess | ||||||
| Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF… | homo-6-mer | 30×IOD; 54×CL; 6×1B0; | ||||
| Assess | ||||||
| Structure of the V11I/T58A/I124A mutant of the HIV-1 capsid protein | homo-6-mer | 42×IOD; 54×CL; | ||||
| Assess | ||||||
| N74D mutant of the HIV-1 capsid protein | homo-6-mer | 36×IOD; | ||||
| Assess | ||||||
| Structure of HIV-1 CA 1/2-hexamer | homo-6-mer | 6×NA; | ||||
| Assess | ||||||
| Structure of HIV-1 CA P207S | homo-6-mer | 18×IOD; 12×CL; | ||||
| Assess | ||||||
| Structure of HIV-1 CA G208R | homo-6-mer | 12×IOD; | ||||
| Assess | ||||||
| Structure of HIV-1 CA T210K | homo-6-mer | 12×IOD; 12×CL; | ||||
| Assess | ||||||
| HIV-1 mature capsid hexamer from CA-IP6 CLPs | homo-6-mer | |||||
| Assess | ||||||
| CryoEM Structure Refinement by Integrating NMR Chemical Shifts with Molecular Dynamics Simulations | homo-6-mer | |||||
| Assess | ||||||
| HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs | homo-6-mer | |||||
| Assess | ||||||
| Co-crystal structure of GS-6207 bound to HIV-1 capsid hexamer | homo-6-mer | 6×QNG; 12×IOD; 24×CL; | ||||
| Assess | ||||||
| Structure of M66I mutant of disulfide stabilized HIV-1 CA hexamer | homo-6-mer | 18×IOD; 21×CL; | ||||
| Assess | ||||||
| Structure of the I124A mutant of the HIV-1 capsid protein | homo-6-mer | 54×IOD; 60×CL; | ||||
| Assess | ||||||
| Structure of the T58A/I124A mutant of the HIV-1 capsid protein | homo-6-mer | 48×IOD; 54×CL; | ||||
| Assess | ||||||
| Structure of the native full-length dehydrated HIV-1 capsid protein | homo-6-mer | 12×CL; 6×1PE; | ||||
| Assess | ||||||
| Co-crystal structure of lenacapavir bound to N74D mutant of disulfide stabilized HIV-1 CA hexamer | homo-6-mer | 6×QNG; 36×CL; 6×IOD; | ||||
| Assess | ||||||
| Hexamer of Helical HIV capsid by RASTR method | homo-6-mer | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00100439 | homo-6-mer | 12×EDO; 6×WVU; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00057456 | homo-6-mer | 6×AJ2; | ||||
| Assess | ||||||
| Potent long-acting inhibitors targeting HIV-1 capsid based on a versatile quinazolin-4-one scaffold | homo-6-mer | 15×EDO; 6×Y05; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00074110 | homo-6-mer | 6×WVZ; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00100452 | homo-6-mer | 24×EDO; 6×WWR; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00100555 | homo-6-mer | 6×3IP; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00024969 | homo-6-mer | 6×XXL; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA H12Y mutant | homo-6-mer | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01829021 | homo-6-mer | 6×WZL; 18×EDO; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01728501 | homo-6-mer | 6×X0L; 6×EDO; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA, apo form | homo-6-mer | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with hexacarboxybenzene | homo-6-mer | 6×BHC; | ||||
| Assess | ||||||
| Disulfide stabilized HIV-1 CA hexamer 4mut (S41A, Q67H, V165I, L172I) in complex with PF-3450074 | homo-6-mer | 6×1B0; | ||||
| Assess | ||||||
| HIV-1 CA hexamer in complex with IP6, hexagonal crystal form | homo-6-mer | 6×IHP; | ||||
| Assess | ||||||
| HIV capsid hexamer with IP6 ligand | homo-6-mer | 6×IHP; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA R18G mutant | homo-6-mer | |||||
| Assess | ||||||
| Crystal structure of the HIV capsid hexamer bound to the small molecule long-acting inhibitor, GS-6… | homo-6-mer | 6×QNG; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01829894 | homo-6-mer | 12×EDO; 6×WZ9; | ||||
| Assess | ||||||
| Disulfide stabilized HIV-1 CA hexamer 4mut (S41A, Q67H, V165I, L172I) | homo-6-mer | |||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01044153 | homo-6-mer | 6×WZR; 6×EDO; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with dATP | homo-6-mer | 6×DTP; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with PF3450074 | homo-6-mer | 6×CL; 6×1B0; | ||||
| Assess | ||||||
| HIV-1 capsid hexamer R18D mutant | homo-6-mer | |||||
| Assess | ||||||
| Structure of Q67H mutant of disulfide stabilized HIV-1 CA hexamer | homo-6-mer | 36×IOD; 24×CL; | ||||
| Assess | ||||||
| Structure of Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexamer | homo-6-mer | 24×IOD; 30×CL; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01728505 | homo-6-mer | 6×X0H; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in Complex with BI-2 | homo-6-mer | 6×EDO; 6×3A8; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD00100333 | homo-6-mer | 12×EDO; 6×S0I; | ||||
| Assess | ||||||
| Co-crystal structure of lenacapavir bound to Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexa… | homo-6-mer | 6×QNG; 24×CL; 6×IOD; | ||||
| Assess | ||||||
| Co-crystal structure of Q67H mutant of disulfide stabilized HIV-1 CA hexamer and lenacapavir | homo-6-mer | 6×QNG; 18×IOD; 24×CL; | ||||
| Assess | ||||||
| Hexameric HIV-1 CA in complex with DDD01728503 | homo-6-mer | 12×EDO; 6×WZX; | ||||
| Assess | ||||||
| HIV capsid hexamer with IP5 ligand | homo-6-mer | |||||
| Assess | ||||||
| Hexameric HIV-1 CA, open conformation | homo-6-mer | 6×1B0; 1×CL; | ||||
| Assess | ||||||
| Hexameric HIV-1 (M-group) CA Q50Y mutant | homo-6-mer | |||||
| Assess | ||||||
| X-ray Structure of Hexameric HIV-1 CA | homo-6-mer | |||||
| Assess | ||||||
| Disulfide-stabilized HIV-1 CA hexamer in complex with PQBP1 Nt | homo-6-mer | |||||
| Assess | ||||||
| Immature HIV-1 CACTD-SP1 lattice with Inositol hexakisphosphate (IP6) | homo-6-mer | 1×IHP; | ||||
| Assess | ||||||
| Immature HIV-1 CACTD-SP1 lattice with Bevirimat (BVM) and Inositol hexakisphosphate (IP6) | homo-6-mer | 1×IHP; 1×2I4; | ||||
| Assess | ||||||
| Crystal structure of Pr55Gag-matrix domain in complex with IP6 in space group C121 | homo-3-mer | 3×IHP; | ||||
| Assess | ||||||
| Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 2 | homo-3-mer | 1×12P; 5×SO4; 1×ACT; | ||||
| Assess | ||||||
| X-ray structure of the HIV-1 myristoylated matrix protein | homo-3-mer | 3×MYR; 3×1PE; 3×CIT; | ||||
| Assess | ||||||
| Crystal Structure Human Immunodeficiency Virus-1 Matrix protein Mutant Q63R Crystal Form 1 | homo-3-mer | 3×P6G; 7×SO4; | ||||
| Assess | ||||||
| Hexamer-2-Foldon HIV-1 capsid platform | homo-2-mer | |||||
| Assess | ||||||
| Structure of HIV-1 CA 1/3-hexamer | homo-2-mer | 1×ACT; | ||||
| Assess | ||||||
| Dimerization interface of the noncrystalline HIV-1 capsid protein lattice from solid state NMR spec… | homo-2-mer | |||||
| Assess | ||||||
| Atomic-Resolution Structure of HIV-1 Capsid Tubes by Magic Angle Spinning NMR | monomer | |||||
| Assess | ||||||
| Structure of HIV-1 CAcSP1NC mutant(W41A,M42A) interacting with maturation inhibitor EP39 | monomer | 2×ZN; | ||||
| Assess | ||||||
| STRUCTURE OF THE N-TERMINAL DOMAIN OF THE MATURE HIV-1 CAPSID PROTEIN | monomer | |||||
| Assess | ||||||
| Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Protein | monomer | |||||
| Assess | ||||||
| Solution structures of HIV-1 and SIVmac p6 and their interaction with accessory proteins Vpr and Vp… | monomer | |||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7t15.1.A | monomer | 0.73 | 84.85 | |||
| Assess | ||||||
| 1l6n.1.A | monomer | 0.70 | 100.00 | |||
| Assess | ||||||
| 7asl.1.A | monomer | 0.66 | 97.87 | |||
| Assess | ||||||
| 1esk.1.A | monomer | 0.57 | 2×ZN; | 92.86 | ||
| Assess | ||||||